Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares Business Wire Silence Therapeutics plc (“Silence” or the “Company”), a global clinical-stage biotechnology company developing novel short interfering RNA (“siRNA”) therapies, today announced that it has commenced an underwritten public offering of approximately $150 million of its American Depositary Shares (“ADSs”), each representing three ordinary shares of £0.05 each in the capital of the Company, in the [...]
Smurfit Westrock plc: Form 10-Q for the Quarterly Period Ended June 30, 2026 Business Wire Today Smurfit Westrock plc (the “Company”) filed its quarterly report on Form 10-Q for the quarterly period ended June 30, 2026 with the U.S Securities and Exchange Commission (the “SEC”). The Form 10-Q is available to view on the SEC’s website at: https://www.sec.gov and the Company’s website at: https://investors.smurfitwestrock.com/financials/sec-filings/default.aspx View source version on businesswire.com: https://www.businesswire.com/news/home/20260731145091/en/ [...]
IGI Announces That It Has Filed Its Full Year 2025 Annual Report on Form 20-F, Including Audited Financial Statements, With the SEC Business Wire International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today announced that it has filed its Annual Report on Form 20-F, which includes the Company’s audited financial statements for the year ended December 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”). The report was filed on April 21, 2026 and can [...]
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Kolibri Global Energy Inc.’s Shareholders Vote Against the Share Limit Resolution Proposed by TFG Asset Management UK LLP November 11, 2025 Your vote is important no matter how many Kolibri shares you hold. Kolibri’s board of directors carefully reviewed the Share Limit Resolution and determined that its adoption would be detrimental to shareholders and not in the best interests of the Company. Management and the Board unanimously recommend that shareholders vote AGAINST the Proposed Resolution. For assistance with voting, please contact Barbara Fox by phone at 1-805-484-3613 ext. 231, or by email at [email protected].